Waltz is leading a new way forward for prescription care. Led by a team of industry experts, Waltz is fixing the high costs and broken experiences that define the pharmaceutical supply chain. Waltz is introducing AI-driven marketplaces that drive down costs, and new consumer tools that guide decisions on care. Our solutions are designed with payers, pharmacies, and consumers in mind.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
04/27/22 | $35,400,000 | Series A |
Blue Venture Fund Byers Capital Define Ventures Echo Health Ventures GV Twine Ventures | undisclosed |